Research Scientist - Charlottesville, United States - University of Virginia

University of Virginia

Verified Company

Charlottesville, United States

3 weeks ago

Posted by:

Mark Lane

beBee recruiter

Description

The Department of Surgery at the University of Virginia School of Medicine seeks a Research Scientist to conduct research in the lab of Dr.

Kenneth Brayman.

The Brayman Lab is currently focused on polyclonal Immunoglobulin M and Adenosine A2A Receptor (A2AR) agonist therapies as cures for type 1 diabetes and interventions to promote longitudinal islet transplantation outcomes.

Conduct independent research under the guidance of a scientific mentor within the Department of Surgery.
Serve as collaborator, and supervisor of postdoctoral, medical and graduate students, residents, and laboratory technicians within the lab;
Develop and test hypotheses;
Plan, design and execute advanced research experiments;
Develop and implement new research techniques and methodologies in the laboratory in compliance with federal and institutional laboratory and safety regulations;
Conduct significant statistical analysis, evaluation and interpretation of raw data;
Assist in writing grants for research funding; plan and write manuscripts, articles, abstracts and research reports for publication in peerreviewed journals;
Other duties as assigned

QUALIFICATIONS
Applicants must have a doctoral degree in hand by start date. A masters degree with significant experience may also be accepted.

This position will remain open until filled. The University will perform background checks on all new hires prior to employment. A completed pre-employment health screen is required for this position prior to employment.

TO APPLY

CV or Resume
Cover letter
Contact information for three professional references

Upload all materials into the resume submission field, multiple documents can be submitted into this one field. Alternatively, merge all documents into one PDF for submission. Applications that do not contain all required documents will not receive full consideration.